Many drug development plans also fail from the early-stage outset because they do not understand the right strategies and questions that must be defined early on and in each phase of the drug development process.
In addition, clinical study delays have been shown to cost sponsors between $600,000 and $8M for each day a trial delays a product development launch. Leveraging effective strategies and innovations is crucial to reducing costs, timelines, and improving the probability of success in a process already prone to high failure.
Each phase from early to commercialization requires different strategies that need to be integrated at the appropriate time.
We leverage strategic intelligence and insights to help you accelerate your clinical development program with our:
Our Seven Point Solution
Leveraging our proprietary Accelerate by BHG™, we Identify a battery of actions across various functions and help you define strategies and key questions for each clinical development phase to improve your clinical trial or program’s chances of success.
Understand the Therapeutic and Commercial Landscape for your potential new drug.
A thorough landscape assessment can inform endpoints and answer questions such as:
- What are the un-met needs in your therapy area?
- Is there a competing therapy in development that could change the standard of care?
- What are the critical value drivers for those patients?
- What will the therapeutic environment likely be when the treatment is launched?
Analyze the inclusion of key innovations that can optimize your clinical trial and accelerate its development some examples include:
- Decentralized/virtual trials
- Real World Evidence
- Patient Centricity
- Precision medicine and biomarkers
Develop a Target Product Profile and or Clinical Development Plan to guide you across the clinical and commercial integration of your drug development program at the early stages of the journey
Increase Patient Diversity in your clinical trial leveraging our connections with over 500 US sites and communities in under-represented populations
Leverage intelligent analytics and industry leading data to optimize your study design, site, and country selection to maximize the success of your clinical trial
CRO Selection and Management: Selecting the right CRO is crucial to your drug development as a wrong selection can results in added delays, lack of cultural fit and cost you time and money. Leverage our experience with multiple CRO’s to help you make the right decision
We work across all therapeutic areas such as Oncology, Rare Disease. CNS, Immunology etc. and are flexibly designed to work with all types of bio-pharmaceutical companies and especially small to midsized biotech companies.
Let us put our insight and intelligence to work for you.
We are flexibly designed to all types of bio-pharmaceutical companies, our approach is to work as a true partner and be flexible, with the high-quality strategic guidance and the support your company deserves.
